OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $37,000 | -94.3% | 65,197 | -82.6% | 0.00% | -100.0% |
| Q4 2015 | $645,000 | -74.7% | 374,934 | -69.0% | 0.00% | -66.7% |
| Q3 2015 | $2,550,000 | -69.5% | 1,208,850 | -28.5% | 0.00% | -62.5% |
| Q2 2015 | $8,373,000 | -36.3% | 1,691,547 | +0.7% | 0.01% | -38.5% |
| Q1 2015 | $13,147,000 | +30.6% | 1,679,047 | +1.1% | 0.01% | +30.0% |
| Q4 2014 | $10,066,000 | +42.3% | 1,661,047 | 0.0% | 0.01% | +42.9% |
| Q3 2014 | $7,076,000 | -37.1% | 1,661,047 | -8.8% | 0.01% | -36.4% |
| Q2 2014 | $11,257,000 | -3.1% | 1,821,547 | +2.0% | 0.01% | -8.3% |
| Q1 2014 | $11,613,000 | +46.6% | 1,786,547 | +26.9% | 0.01% | +33.3% |
| Q4 2013 | $7,924,000 | -18.0% | 1,407,547 | -10.5% | 0.01% | -25.0% |
| Q3 2013 | $9,659,000 | +51.7% | 1,573,097 | +44.5% | 0.01% | +50.0% |
| Q2 2013 | $6,367,000 | – | 1,088,297 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,235,000 | $5,261,000 | 5.04% |
| Cheyne Capital Management (UK) LLP | 693,642 | $2,958,000 | 1.05% |
| Rock Springs Capital Management LP | 1,250,000 | $5,325,000 | 0.82% |
| NEA Management Company, LLC | 3,709,000 | $15,800,000 | 0.80% |
| Rhenman & Partners Asset Management AB | 494,000 | $2,104,000 | 0.62% |
| Palo Alto Investors LP | 1,931,324 | $8,227,000 | 0.62% |
| PFM Health Sciences, LP | 4,838,324 | $20,611,000 | 0.47% |
| CQS Cayman LP | 1,750,000 | $7,455,000 | 0.44% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,700,371 | $7,243,000 | 0.37% |
| SAMLYN CAPITAL, LLC | 2,299,000 | $9,794,000 | 0.20% |